From: The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women
Quartile of FEV1 | 1 | 2 | 3 | 4 | Trend Test (p value)†|
---|---|---|---|---|---|
Range of FEV1 (% predicted) | 103 to 149 | 88 to 102 | 74 to 88 | 43 to 74 | Â |
Number of subjects | 55 | 56 | 55 | 56 | Â |
Unadjusted Odds for Adenocarcinoma | 1 (reference) | 0.83 (0.33–2.05) | 0.35 (0.14–0.81) | 0.75 (0.31–1.84) | 0.216 |
Adjusted Odds for Adenocarcinoma* | 1 (reference) | 0.94 (0.36–2.48) | 0.44 (0.18–1.09) | 0.88 (0.34–2.32) | 0.448 |
 | 1 (reference) |  |  |  |  |
Unadjusted Odds for Squamous Cell Carcinoma | 1 (reference) | 0.86 (0.32–2.32) | 3.00 (1.25–7.18) | 1.23 (0.48–3.13) | 0.194 |
 | 1 (reference) |  |  |  |  |
Adjusted Odds for Squamous Cell Carcinoma* | 1 (reference) | 0.71 (0.25–2.06) | 2.19 (0.85–5.61) | 0.92 (0.33–2.54) | 0.567 |